Theriva Biologics, Inc.
TOVX
$0.32
-$0.02-5.60%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.00M | -4.36M | -13.06M | -4.32M | -4.45M |
| Total Depreciation and Amortization | 27.00K | 28.00K | 27.00K | 26.00K | 27.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 636.00K | 540.00K | 9.01M | -168.00K | 245.00K |
| Change in Net Operating Assets | -1.55M | -526.00K | -693.00K | -290.00K | -516.00K |
| Cash from Operations | -2.88M | -4.32M | -4.71M | -4.76M | -4.69M |
| Capital Expenditure | 0.00 | -19.00K | -16.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -19.00K | -16.00K | -- | 0.00 |
| Total Debt Issued | 15.00K | 34.00K | 57.00K | 1.40M | -- |
| Total Debt Repaid | -1.00K | -2.00K | -11.00K | -56.00K | 0.00 |
| Issuance of Common Stock | 10.50M | 279.00K | 6.69M | -- | 7.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.05M | -459.00K | 71.00K | 1.73M | -- |
| Cash from Financing | 8.46M | -148.00K | 6.81M | 3.07M | 7.00K |
| Foreign Exchange rate Adjustments | -48.00K | -106.00K | -31.00K | 93.00K | -123.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.53M | -4.59M | 2.05M | -1.59M | -4.81M |